Skip to main content
. 2011 Sep 28;12:214. doi: 10.1186/1745-6215-12-214

Table 2.

Characteristics of included trials

Trial Characteristics Percent (number) of Trials
Study Type
 Individual patient RCT 76.25% (61/80)
 Factorial RCT 6.25% (5/80)
 Cluster RCT 17.5% (14/80)

Number of study arms
 Two 83.75% (67/80)
 Three 7.5% (6/80)
 Four 8.75% (7/80)

Patient Population
 Adults 91.25% (73/80)
 Children 6.25% (5/80)
 Infants 1.25% (1/80)
 Mixed (Adults & Children) 1.25% (1/80)

Study Intervention
 Drug 46.25% (37/80)
 Surgery 8.75% (7/80)
 Education 10.0% (8/80)
 Other 27.5% (22/80)
 Procedure 3.75% (3/80)
 Weight loss 3.75% (3/80)

Funding Source
 Academic 73.75% (59/80)
 Industry 26.25% (21/80)

Trial start-up meeting described 8.75% YES (7/80)

Trial run-in phase described 8.75% YES (7/80)

GCP adherence reported 6.25% YES (5/80)

Lead Investigator reports previous research experience 62.5% YES (50/80)

Trial results
 Harm 2.5% (2/80)
 Neutral 32.5% (26/80)
 Positive 65.0% (52/80)

Management structure
 MC, SC & others (explicit structure) 26.25% (21/80)
 MC or SC only (basic structure) 21.25% (17/80)
 Not reported 52.8% (42/80)

Abbreviations: RCT - Randomised controlled trials; MC - Management Committee; SC - Steering Committee; GCP - Good Clinical Practice.